Reuters logo
BRIEF-Impax announces FDA approval and launch of a generic version of vytorin
April 26, 2017 / 8:17 PM / 5 months ago

BRIEF-Impax announces FDA approval and launch of a generic version of vytorin

April 26 (Reuters) - Impax Laboratories Inc:

* Impax announces FDA approval and launch of a generic version of vytorin (ezetimibe/simvastatin tablets)

* Impax Laboratories Inc - received final FDA approval for a generic version of vytorin and immediately initiated commercialization activities Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below